Dyslipidaemia

Ischaemic heart disease - Dyslipidaemia Factor

RMA definition of dyslipidaemia used in SoPs 2006 - present

There are minor differences in these definitions and you will need to check that the definition is met for the particular condition being investigated (see hotwords for the conditions and relevant definition).

General information about dyslipidaemia

Lipids are naturally occurring substances consisting of fatty acids.  The term dyslipidaemia describes the presence of abnormal lipid levels.  Hyperlipidaemia, hypertriglyceridaemia and hypercholesterolaemia are forms of dyslipidaemia.

Signs and symptoms

Dyslipidaemia does not usually cause any symptoms although unsightly xanthomas (fatty fibrous changes in the skin associated with the formation of yellow or yellowish-brown plaques, nodules or tumours) are sometimes a feature of some lipid disorders.  However, the presence of dyslipidaemia as defined by the RMA can be established only by laboratory analysis of a blood sample (usually after fasting).

Establishing onset

Only a blood test can establish the onset of dyslipidaemia and the result of such a test would normally be recorded in doctors' notes and/or hospital records.  However, if these records have been destroyed or can no longer be obtained and there is a reliable history of dyslipidaemia at a particular time, this generally will be accepted, unless there is contradictory evidence.  Obtain medical advice if it is unclear whether the claimed symptoms and treatment at that time can be attributed to dyslipidaemia rather than to some other condition.

Last reviewed for CCPS 27 April 2010.

Preliminary questions [7881]

29977 there is some evidence that dyslipidaemia may be a factor in the development or worsening of the condition under consideration.

7927     the veteran has had dyslipidaemia at some time.

7928     the veteran has established the causal connection between the dyslipidaemia and VEA service for ischaemic heart disease.

7929     the veteran had dyslipidaemia before the clinical onset of the condition under consideration.

7931     the veteran has established the causal connection between the dyslipidaemia and VEA service for the clinical onset of ischaemic heart disease.

7933     the veteran has established the causal connection between the dyslipidaemia and operational service for the clinical onset of ischaemic heart disease.

or

7934     the veteran has established the causal connection between the dyslipidaemia and eligible service for the clinical onset of ischaemic heart disease.

or

7334     the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

7335     the condition under consideration permanently worsened.

7930     the veteran had dyslipidaemia before the clinical worsening of the condition under consideration.

7932     the veteran has established the causal connection between the dyslipidaemia and VEA service for the clinical worsening of ischaemic heart disease.

7935     the veteran has established the causal connection between the dyslipidaemia and operational service for the clinical worsening of ischaemic heart disease.

or

7936     the veteran has established the causal connection between the dyslipidaemia and eligible service for the clinical worsening of ischaemic heart disease.

Clinical onset and operational service [7933]

25967  the dyslipidaemia is causally related to operational service.

Clinical onset and eligible service [7934]

25968  the dyslipidaemia is causally related to eligible service.

Clinical worsening and operational service [7935]

25967  the dyslipidaemia is causally related to operational service.

7939     the clinical onset of the condition under consideration occurred prior to that part of operational service to which the dyslipidaemia is causally related.

Clinical worsening and eligible service [7936]

25968  the dyslipidaemia is causally related to eligible service.

7940     the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the dyslipidaemia is causally related.